Lateral thinking identifies a new way to restore function to stressed and diseased tissues in humans and mammals
Lateral Pharma has discovered a new family of naturally-derived peptide motifs that are effective in multiple animal models of neuropathic pain, osteoarthritis, obesity, COPD, EMCV and severe influenza A infection. Small synthetic peptides variants from growth hormone and four other proteins interact with a novel class of target to restore normal tissue function under conditions of damage, attack and cellular stress. No significant safety issues have been identified in preclinical and human clinical studies, which is predictable from the mechanism of action Lateral has identified. These discoveries have been protected by a substantial portfolio of patent filings.